May 6, 2024 11:16 am EDT Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Apr 25, 2024 8:00 am EDT Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Apr 11, 2024 8:00 am EDT Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Mar 28, 2024 4:01 pm EDT Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Mar 20, 2024 8:00 am EDT Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Mar 14, 2024 8:00 am EDT Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Mar 6, 2024 8:00 am EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Feb 29, 2024 8:01 am EST Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Feb 29, 2024 8:00 am EST Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
Dec 11, 2023 4:30 pm EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences